Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Phyto Chem (India) Ltd

PHYTO
BSE
24.00
3.19%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Phyto Chem (India) Ltd

PHYTO
BSE
24.00
3.19%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
10Cr
Close
Close Price
24.00
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
PS
Price To Sales
1.00
Revenue
Revenue
10Cr
Rev Gr TTM
Revenue Growth TTM
-21.33%
PAT Gr TTM
PAT Growth TTM
72.90%
Peer Comparison
How does PHYTO stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
PHYTO
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
517705441243
Growth YoY
Revenue Growth YoY%
45.4-54.6-42.2-17.4-91.0620.3-39.4-43.9224.4-67.5-0.2-18.6
Expenses
ExpensesCr
427646433253
Operating Profit
Operating ProfitCr
1-111-3-110-1-100
OPM
OPM%
12.8-200.07.511.7-731.1-22.312.84.7-71.9-34.0-10.1-8.4
Other Income
Other IncomeCr
000020021000
Interest Expense
Interest ExpenseCr
111000011000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
0-200-2-102-1-1-10
Tax
TaxCr
000000000000
PAT
PATCr
0-200-2-102-10-10
Growth YoY
PAT Growth YoY%
140.0-12.1-108.1193.6-1,525.016.5168.8424.132.267.3-609.1-131.6
NPM
NPM%
2.4-275.0-2.24.5-380.0-31.92.541.6-79.5-32.0-12.8-16.2
EPS
EPS
0.3-4.1-0.40.7-4.0-3.40.33.5-2.7-1.1-1.3-1.1

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
432347595944442327151410
Growth
Revenue Growth%
39.3-46.6104.025.90.0-25.20.6-48.015.8-44.6-4.9-26.9
Expenses
ExpensesCr
402244575742422224181513
Operating Profit
Operating ProfitCr
323222213-3-1-2
OPM
OPM%
6.26.66.13.64.14.35.06.19.7-22.1-9.6-21.9
Other Income
Other IncomeCr
010211110222
Interest Expense
Interest ExpenseCr
222222222222
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
101110000-3-1-3
Tax
TaxCr
000000000000
PAT
PATCr
101110000-3-1-3
Growth
PAT Growth%
-11.2-80.0673.28.6-20.9-38.710.6-53.4-3.3-1,597.670.2-170.3
NPM
NPM%
1.30.51.81.61.21.01.11.00.8-22.5-7.0-26.0
EPS
EPS
1.30.32.02.11.71.01.10.50.5-7.8-2.3-6.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
444444444444
Reserves
ReservesCr
344556666321
Current Liabilities
Current LiabilitiesCr
251931456053302425212019
Non Current Liabilities
Non Current LiabilitiesCr
232344544321
Total Liabilities
Total LiabilitiesCr
363042587368453840322825
Current Assets
Current AssetsCr
312538536762413436282522
Non Current Assets
Non Current AssetsCr
444566444433
Total Assets
Total AssetsCr
363042587368453840322825

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-202131-13132
Investing Cash Flow
Investing Cash FlowCr
0100-1010001
Financing Cash Flow
Financing Cash FlowCr
20-2-1-2-10-3-2-3-3
Net Cash Flow
Net Cash FlowCr
00000000000
Free Cash Flow
Free Cash FlowCr
-201-1210313
CFO To PAT
CFO To PAT%
-390.3-314.0181.583.3384.8334.0-144.31,482.0640.5-102.5-178.5
CFO To EBITDA
CFO To EBITDA%
-80.4-22.753.535.5115.377.6-32.3241.854.7-104.5-131.7

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1213232512879141412
Price To Earnings
Price To Earnings
21.4111.726.727.717.217.314.938.263.10.00.0
Price To Sales
Price To Sales
0.30.60.50.40.20.20.20.40.50.90.9
Price To Book
Price To Book
1.51.62.72.91.30.80.70.81.31.91.9
EV To EBITDA
EV To EBITDA
10.118.814.320.214.115.412.021.112.9-9.7-21.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
27.835.830.119.416.120.420.634.233.012.217.7
OPM
OPM%
6.26.66.13.64.14.35.06.19.7-22.1-9.6
NPM
NPM%
1.30.51.81.61.21.01.11.00.8-22.5-7.0
ROCE
ROCE%
10.58.010.612.39.69.18.87.27.9-5.03.6
ROE
ROE%
7.01.410.210.47.74.54.82.22.1-45.3-15.5
ROA
ROA%
1.50.42.01.61.00.71.10.60.6-10.5-3.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Phyto Chem (India) Limited is an established Indian agrochemical player currently undergoing a strategic pivot. While its historical core competency lies in the manufacturing of pesticide formulations, the company is aggressively diversifying into industrial sectors—specifically ferroalloys—to mitigate the volatility of the agricultural market and drive a recovery in shareholder value. --- ### **Core Manufacturing Capabilities & Infrastructure** The company operates a centralized, integrated manufacturing hub in Southern India, focusing on self-reliance and indigenous technical development. * **Integrated Facility:** The primary manufacturing unit and registered office are located at **Bonthapally, Sangareddy District, Telangana**. * **Production Capacity:** The facility maintains a total production capacity of **90,00,000 Liters/Kilograms** per annum. * **Technological Independence:** The company utilizes **100% indigenous technology**. No foreign technology has been imported in the last **three years**, reflecting a self-sustained operational model. * **R&D and Innovation:** An in-house Research & Development division focuses on developing **new viable products** and optimizing existing manufacturing processes. R&D costs are integrated into operational expenses rather than accounted for separately. * **Sustainability Initiatives:** Management is currently evaluating the installation of **Solar Street Lights** and **Solar Panels** to power plant lighting and reduce carbon footprints. --- ### **Strategic Business Segments** Phyto Chem has restructured its operations into three distinct segments to balance seasonal agricultural risks with steady industrial demand. | Segment | Focus Area | Status | | :--- | :--- | :--- | | **Pesticide Formulations** | Liquid/SC, Weedicides, Wettable Powders, and Granules. | Core / Consolidating | | **Ferro Alloy Products** | Manufacturing and supply under a loan licensing agreement. | High-Growth / New | | **Real Estate** | Sale of residual land parcels and price escalation settlements. | Secondary / Residual | * **Pesticides (Agri-Business):** Operates through an established dealer network across **Telangana, Andhra Pradesh, Maharashtra, and Karnataka**. Due to intense competition, the company has intentionally avoided exports, focusing exclusively on the domestic market where it can leverage its brand. * **Ferroalloys (Industrial-Business):** Launched in **FY 2024-25** via a manufacturing loan licensing agreement with **M/s. Siri Smelters & Energy Private Limited**. This segment has rapidly scaled, contributing **30% to 42%** of total sales in recent quarters and providing a much-needed profit cushion of **₹66.79 lakhs** as of December 2024. * **Real Estate:** While not a core focus, this segment provides periodic liquidity. The company received price escalation settlements of **₹2 crore** in **FY 2023-24** and **₹1.5 crore** in **FY 2024-25**. --- ### **Financial Performance & Recovery Targets** The company is emerging from a period of financial contraction characterized by a **36.36%** turnover decrease in **FY 2023-24**. Management has set aggressive targets for a turnaround. **Revenue and Profitability Trajectory:** * **FY 2022-23:** Turnover of **₹26.92 crore** with a PAT of **₹0.22 crore**. * **FY 2023-24:** Turnover dropped to **₹17.13 crore** with a Net Loss of **₹(3.33) crore**. * **FY 2024-25 (Est):** Turnover of **₹16.55 crore** with a narrowed Net Loss of **₹(0.97) crore**. * **FY 2025-26 (Target):** Management is targeting a total turnover of **₹32.75 crore**—representing a projected growth of approximately **98%**, driven primarily by the Ferroalloy expansion. **Capital Structure & Liquidity:** * **Paid-up Capital:** **₹4.3 crore** (43,00,200 shares at **₹10/-** par value). * **Market Valuation:** Market Capitalization stood at **₹1,374.77 lakhs** (as of March 31, 2024) with a closing price of **₹31.97** on the BSE. * **Working Capital:** Secured by the hypothecation of inventory and book debts, further supported by personal guarantees from the **Managing Director** and **Executive Director**. Cash and equivalents remained tight at **₹4.61 lakhs** as of March 2025. --- ### **Operational Risks & Mitigation Strategies** Phyto Chem operates in a high-risk environment influenced by climate, credit, and competition. * **Climatic & Market Volatility:** The pesticide business is highly sensitive to **monsoon conditions**. Recent shortfalls in rain led to reduced crop acreage. To mitigate this, the company is shifting weight toward the **Ferroalloy market**, which it views as "highly reliable." * **Credit Risk:** The industry demands an **unlimited credit period**, leading to challenges in timely collections. The company has implemented the **Ind AS 109 Expected Credit Loss (ECL)** model to better manage receivables. * **Cost Pressures:** Manufacturing expenses as a percentage of sales rose from **69.15%** to **79.55%** in one year. In response, the company initiated **Cost Rationalization**, including a **24.23%** reduction in Managerial Remuneration and a **10.98%** reduction in general employee salaries. * **Foreign Exchange:** Outflow for raw materials was reduced from **₹1.24 crore** in **FY 2022-23** to **Nil** in the most recent period, as the company pivoted away from import-heavy requirements. --- ### **Governance & Leadership** To ensure stability during its strategic transition, the company has secured long-term commitments from its top leadership and is strengthening board oversight. * **Executive Leadership:** * **Mr. Y. Nayudamma (Managing Director):** Re-appointed for a 3-year term through **December 2027**. * **Mr. Y. Janaki Ramaiah (Executive Director):** Re-appointed for a 5-year term effective **July 2024**. * **Board Composition:** Recent appointments of Independent Directors, including **Mr. M. Sree Ram Murthy** and **Mr. N. Nagendra Naidu**, aim to address previous difficulties in finding suitable candidates from the national data bank. * **Compliance Note:** The company is working to resolve historical administrative delays, including a **333-day delay** in filing Form MGT-14 for the **FY 2023-24** Directors' Report. --- ### **Investment Outlook** Phyto Chem (India) Limited is currently a "transition story." The legacy pesticide business provides a foundation of infrastructure and brand presence, but the **Ferroalloy segment** is the intended engine for future margin expansion. Investors should monitor the company’s ability to hit its **₹32.75 crore** revenue target for **FY 2025-26** and its success in managing working capital cycles in a high-competition domestic market.